PET-CT indications and contributions to diagnosis in the rheumatology clinic: a retrospective analysis
Clinical Rheumatology · 2025
DOI: 10.1007/s10067-025-07635-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Rheumatology, 2025. Verfasst von Tuğba Kahraman Denizhan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Erciyes University, Kayseri, Türkiye. tugba_dr_@hotmail.com. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Rheumatic Diseases, Neoplasms, Vasculitis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: Positron emission tomography-computed tomography (PET-CT) is a valuable imaging modality in both oncology and autoimmune or inflammatory diseases. This study evaluates the indications for PET-CT in rheumatology patients, compares PET-CT findings with other imaging modalities, and assesses its contribution to definitive diagnosis. METHODS: Between January 2022 and December 2023, 63 patients (38 women, 25 men) who underwent PET-CT at Erciyes University Rheumatology Clinic were retrospectively analyzed. Clinical, laboratory, and imaging findings-including prior CT, magnetic resonance imaging (MRI), and angiographic evaluations-were reviewed. PET-CT findings were classified based on metabolic uptake patterns indicating malignancy, vasculitis, inflammatory involvement, lymphadenopathy, and IgG4-related diseases. PET-CT results were statistically compared with final diagnoses. RESULTS: The most common indications for PET-CT were suspected vasculitis (42.9%), fever/inflammation of unknown origin (30.2%), and suspected malignancy (27.0%). PET-CT detected inflammation in 65.1% of cases, lymphadenopathy in 52.4%, nodules in 41.3%, malignancy in 31.7%, and vasculitis in 20.6%. Vasculitis findings were significantly higher in patients with pre-existing rheumatic disease (p = 0.012), while malignancy-related findings were more frequent in those without (p = 0.025). Anti-SSA and anti-Scl70 positivity were significantly associated with malignancy (p = 0.003 and p = 0.030, respectively). PET-CT effectively detected malignancy (p < 0.001) but showed limited diagnostic accuracy for vasculitis (47.6%). CONCLUSION: PET-CT complements conventional imaging in evaluating vasculitis, inflammation, and malignancy in rheumatic diseases. However, it is insufficient for diagnosing vasculitis alone, necessitating a comprehensive clinical and laboratory approach. While PET-CT is highly effective in malignancy detection, autoantibody presence should be carefully considered in suspected cases. Key points • Positron emission tomography combined with computed tomography is a significant imaging modality in the field of rheumatology, particularly in the assessment of patients with vasculitis, inflammatory diseases, and suspected malignancy. • While PET-CT has been shown to have a high degree of accuracy in detecting malignancy, its reliability in diagnosing vasculitis is limited, with a reported reliability of only 47.6%. • In patients in whom PET-CT was ordered with suspicion of malignancy, a significant association has been demonstrated between anti-SSA and anti-Scl70 positivity and malignancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Erciyes University, Kayseri, Türkiye. tugba_dr_@hotmail.com.
- Aksaray University Training and Research Hospital, Aksaray, Türkiye.
- Kayseri City Hospital, Kayseri, Türkiye.
- Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Erciyes University, Kayseri, Türkiye.
- Department of Nuclear Medicine, Faculty of Medicine, Erciyes University, Kayseri, Türkiye.
Zitieren
APA
Denizhan, T. K., Kaplan, H., Kızıltepe, M., Kökoğlu, E. O., Cengiz, C. B., Abdulrezzak, U., & Şenel, A. S. (2025). PET-CT indications and contributions to diagnosis in the rheumatology clinic: a retrospective analysis. Clinical Rheumatology. https://doi.org/10.1007/s10067-025-07635-1
Vancouver
Denizhan TK, Kaplan H, Kızıltepe M, Kökoğlu EO, Cengiz CB, Abdulrezzak U, et al. PET-CT indications and contributions to diagnosis in the rheumatology clinic: a retrospective analysis. Clinical Rheumatology. 2025. doi:10.1007/s10067-025-07635-1
BibTeX
@article{Denizhan2025,
author = {Denizhan, Tuğba Kahraman and Kaplan, Hüseyin and Kızıltepe, Melih and Kökoğlu, Emel Oğuz and Cengiz, Celil Barlas and Abdulrezzak, Ummuhan and Şenel, Abdurrahman Soner},
title = {PET-CT indications and contributions to diagnosis in the rheumatology clinic: a retrospective analysis},
journal = {Clinical Rheumatology},
year = {2025},
doi = {10.1007/s10067-025-07635-1}
}
EUVIMED